nn9b04315_si_001.pdf (1.88 MB)
Enzyme-Driven Membrane-Targeted Chimeric Peptide for Enhanced Tumor Photodynamic Immunotherapy
journal contribution
posted on 2019-10-02, 15:04 authored by Chi Zhang, Fan Gao, Wei Wu, Wen-Xiu Qiu, Lu Zhang, Runqing Li, Ze-Nan Zhuang, Wuyang Yu, Han Cheng, Xian-Zheng ZhangHere,
a protein farnesyltransferase (PFTase)-driven plasma membrane
(PM)-targeted chimeric peptide, PpIX-C6-PEG8-KKKKKKSKTKC-OMe (PCPK), was designed for PM-targeted photodynamic
therapy (PM-PDT) and enhanced immunotherapy via tumor
cell PM damage and fast release of damage-associated molecular patterns
(DAMPs). The PM targeting ability of PCPK originates from the cellular
K-Ras signaling, which occurs exclusively to drive the corresponding
proteins to PM by PFTase. With the conjugation of the photosensitizer
protoporphyrin IX (PpIX), PCPK could generate cytotoxic reactive oxygen
species to deactivate membrane-associated proteins, initiate lipid
peroxidation, and destroy PM with an extremely low concentration (1
μM) under light irradiation. The specific PM damage further
induced the fast release of DAMPs (high-mobility group box 1 and ATP),
resulting in antitumor immune responses stronger than those of conventional
cytoplasm-localized PDT. This immune-stimulating PM-PDT strategy also
exhibited the inhibition effect for distant metastatic tumors when
combined with programmed cell death receptor 1 blockade therapy.
History
Usage metrics
Categories
Keywords
PEG 8inhibition effectcytoplasm-localized PDTEnhanced Tumor Photodynamic Immunotherapydeactivate membrane-associated proteinslipid peroxidationPM damagehigh-mobility group box 1PM-targeted photodynamic therapycell death receptor 1 blockade therapyimmune-stimulating PM-PDT strategyphotosensitizer protoporphyrinATPDAMPlight irradiationprotein farnesyltransferaseEnzyme-Driven Membrane-Targeted Chimeric Peptidecytotoxic reactive oxygen speciesPCPKmetastatic tumorsPpIX-C 6tumor cell PM damage
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC